Citations (45)
Keep up to date with the latest research on this topic with citation updates for this article.
Articles from other publishers (45)
Nasibeh Mohseninia, Nazanin Zamani-Siahkali, Sara Harsini, Ghasemali Divband, Christian Pirich & Mohsen Beheshti. (2024) Bone Metastasis in Prostate Cancer: Bone Scan Versus PET Imaging. Seminars in Nuclear Medicine 54:1, pages 97-118.
Crossref
Crossref
Cristina Lucas Lucas, Laura García Zoghby, Mariano Amo-Salas, Ángel María Soriano Castrejón & Ana María García Vicente. (2023) Diagnostic and therapeutic impact of PET/CT with 18F-DCFPyL versus 18F-Fluorocholine in initial staging of intermediate-/high-risk prostate cancer: a pilot study. Annals of Nuclear Medicine.
Crossref
Crossref
Akshay Sood, Amar U. Kishan, Christopher P. Evans, Felix Y. Feng, Todd M. Morgan, Declan G. Murphy, Anwar R. Padhani, Peter Pinto, Henk G. Van der Poel, Derya Tilki, Alberto Briganti & Firas Abdollah. (2023) The Impact of Positron Emission Tomography Imaging and Tumor Molecular Profiling on Risk Stratification, Treatment Choice, and Oncological Outcomes of Patients with Primary or Relapsed Prostate Cancer: An International Collaborative Review of the Existing Literature. European Urology Oncology.
Crossref
Crossref
Oguz Akin, Sungmin Woo, Aytekin Oto, Brian C. Allen, Ryan Avery, Samantha J. Barker, Marielia Gerena, David J. Halpern, Lori Mankowski Gettle, Seth A. Rosenthal, Samir S. Taneja, Baris Turkbey, Pat WhitworthIIIIII & Paul Nikolaidis. (2023) ACR Appropriateness Criteria® Pretreatment Detection, Surveillance, and Staging of Prostate Cancer: 2022 Update. Journal of the American College of Radiology 20:5, pages S187-S210.
Crossref
Crossref
Alfredo Berruti, Sergio Bracarda, Orazio Caffo, Enrico Cortesi, Rolando D'Angelillo, Marzia Del Re, Gaetano Facchini, Giovanni Pappagallo, Giuseppe Procopio, Roberto Sabbatini & Daniele Santini. (2023) nmCRPC, a look in the continuous care of prostate cancer patients: state of art and future perspectives. Cancer Treatment Reviews 115, pages 102525.
Crossref
Crossref
I. Martínez-Rodríguez, M. de Arcocha-Torres, F.J. Gómez-de la Fuente, J. Jiménez-Bonilla, A. Sánchez-Salmón, N. Martínez-Amador, V. Mendi-Barcina, J. Andrés-Pacheco, A. Gutiérrez-González, M. Pombo-López, A. Bota-Bota, M. Rodil-Gallego, A. García-Ruiz & R. Quirce. (2023) Effectiveness of 11C-choline PET/CT in prostate cancer surveillance. Revista Española de Medicina Nuclear e Imagen Molecular (English Edition) 42:2, pages 93-99.
Crossref
Crossref
I. Martínez-Rodríguez, M. de Arcocha-Torres, F.J. Gómez-de la Fuente, J. Jiménez-Bonilla, A. Sánchez-Salmón, N. Martínez-Amador, V. Mendi-Barcina, J. Andrés-Pacheco, A. Gutiérrez-González, M. Pombo-López, A. Bota-Bota, M. Rodil-Gallego, A. García-Ruiz & R. Quirce. (2023) Rendimiento de la PET/TC con 11C-colina en el seguimiento del cáncer de próstata. Revista Española de Medicina Nuclear e Imagen Molecular 42:2, pages 93-99.
Crossref
Crossref
Luca Urso, Giovanni Christian Rocca, Francesca Borgia, Federica Lancia, Antonio Malorgio, Mauro Gagliano, Mauro Zanetto, Licia Uccelli, Corrado Cittanti, Carmelo Ippolito, Laura Evangelista & Mirco Bartolomei. (2022) The Role of [18F]F-Choline PET/CT in the Initial Management and Outcome Prediction of Prostate Cancer: A Real-World Experience from a Multidisciplinary Approach. Biomedicines 10:10, pages 2463.
Crossref
Crossref
F. Gómez-Veiga, A. Alcaraz-Asensio, J.M. Burgos-Revilla & F.J. Cózar-Olmo. (2022) Avances en Uro-Oncología «OncoUrology Forum Special Edition»: lo mejor del 2020. Actas Urológicas Españolas 46:4, pages 214-222.
Crossref
Crossref
Marcelo A. Orvieto, Anup Kumar, Siddharth Yadav, Hugo Otaola Arca, F. Rodrigo Pinochet & Renato Souper. 2022. Robotic Urologic Surgery. Robotic Urologic Surgery
117
143
.
F. Gómez-Veiga, A. Alcaraz-Asensio, J.M. Burgos-Revilla & F.J. Cózar-Olmo. (2021) Advances in urologic oncology “OncoUrology Forum Special Edition”: The best of 2020. Actas Urológicas Españolas (English Edition).
Crossref
Crossref
Fanxiao Liu, Jinlei Dong, Yelong Shen, Canhua Yun, Ruixiao Wang, Ganggang Wang, Jiyang Tan, Tao Wang, Qun Yao, Bomin Wang, Lianxin Li, Jingyi Mi, Dongsheng Zhou & Fei Xiong. (2021) Comparison of PET/CT and MRI in the Diagnosis of Bone Metastasis in Prostate Cancer Patients: A Network Analysis of Diagnostic Studies. Frontiers in Oncology 11.
Crossref
Crossref
Raisa S. Abrams-Pompe, Stefano Fanti, Ivo G. Schoots, Caroline M. Moore, Baris Turkbey, Andrew J. Vickers, Jochen Walz, Thomas Steuber & James A. Eastham. (2021) The Role of Magnetic Resonance Imaging and Positron Emission Tomography/Computed Tomography in the Primary Staging of Newly Diagnosed Prostate Cancer: A Systematic Review of the Literature. European Urology Oncology 4:3, pages 370-395.
Crossref
Crossref
Arnoldo Piccardo, Martina Ugolini, Sergio Righi, Gianluca Bottoni, Angelina Cistaro, Francesco Paparo, Luca Giovanella & Laura Evangelista. (2020) Copper, PET/CT and prostate cancer: a systematic review of the literature. The Quarterly Journal of Nuclear Medicine and Molecular Imaging 64:4.
Crossref
Crossref
Mariana Lima, Mariana Camacho, José Barreto Campelo Carvalheira, Aline Biggi, Marcelo Lopes de Lima, Juliana Ciampi, Fernando Salis, Marina Bicalho Silveira, Ubirajara Ferreira & Elba Etchebehere. (2020) The current role of PET/CT in urological malignancies. Clinical and Translational Imaging 8:5, pages 313-347.
Crossref
Crossref
Manil Subesinghe, Meghana Kulkarni & Gary J. Cook. (2020) The Role of PET-CT Imaging in Prostate Cancer. Seminars in Ultrasound, CT and MRI 41:4, pages 373-391.
Crossref
Crossref
J.-P. Abecassis, N. Ghazzar, M. Peyromaure & P. Giraud. (2020) Prostate imaging: Contribution of PET PSMA and MRI. Cancer/Radiothérapie 24:5, pages 423-428.
Crossref
Crossref
Paulina Cegla, Anna Kubiak, Kamila Witkowska & Rafał Czepczyński. (2020) Peyronie Disease as an Example of Nononcological, Inflammatory Uptake of 18F-Fluorocholine in Patient With Prostate Cancer. Clinical Nuclear Medicine 45:7, pages 575-576.
Crossref
Crossref
J.M. Quesada-Olarte, M.E. Allaf, M. Alvarez-Maestro & L. Martínez-Piñeiroa. (2020) Molecular imaging of prostate cancer: Review of imaging agents, modalities, and current status. Actas Urológicas Españolas (English Edition) 44:6, pages 386-399.
Crossref
Crossref
J.M. Quesada-Olarte, M.E. Allaf, M. Alvarez-Maestro & L. Martínez-Piñeiro. (2020) Técnicas de imagen molecular en el cáncer de próstata: revisión de radiofármacos, modalidades y evidencia actual. Actas Urológicas Españolas 44:6, pages 386-399.
Crossref
Crossref
Edouard J. Trabulsi, R. Bryan Rumble, Hossein Jadvar, Thomas Hope, Martin Pomper, Baris Turkbey, Andrew B. Rosenkrantz, Sadhna Verma, Daniel J. Margolis, Adam Froemming, Aytekin Oto, Andrei Purysko, Matthew I. Milowsky, Heinz-Peter Schlemmer, Matthias Eiber, Michael J. Morris, Peter L. Choyke, Anwar Padhani, Jorge Oldan, Stefano Fanti, Suneil Jain, Peter A. Pinto, Kirk A. Keegan, Christopher R. Porter, Jonathan A. Coleman, Glenn S. Bauman, Ashesh B. Jani, Jeffrey M. Kamradt, Westley Sholes & H. Alberto Vargas. (2020) Optimum Imaging Strategies for Advanced Prostate Cancer: ASCO Guideline. Journal of Clinical Oncology 38:17, pages 1963-1996.
Crossref
Crossref
Gary J.R. Cook & Vicky Goh. (2020) Molecular Imaging of Bone Metastases and Their Response to Therapy. Journal of Nuclear Medicine 61:6, pages 799-806.
Crossref
Crossref
Daniela A. Ferraro, Helena I. Garcia Schüler, Urs J. Muehlematter, Daniel Eberli, Julian Müller, Alexander Müller, Roger Gablinger, Helmut Kranzbühler, Aurelius Omlin, Philipp A. Kaufmann, Thomas Hermanns & Irene A. Burger. (2019) Impact of 68Ga-PSMA-11 PET staging on clinical decision-making in patients with intermediate or high-risk prostate cancer. European Journal of Nuclear Medicine and Molecular Imaging 47:3, pages 652-664.
Crossref
Crossref
Moozhan Nikpanah, Esther Mena, Peter L. Choyke & Baris Turkbey. 2020. Prostate MRI Essentials. Prostate MRI Essentials
171
190
.
Jurgen J. Futterer, Cristian Surcel, Roderick van den Bergh, Hendrik Borgmann, Alberto Briganti, Giorgio Gandaglia, Alexander Kretschmer, Piet Ost, Prasanna Sooriakumaran, Derya Tilki, Massimo Valerio, Guillaume Ploussard, Pieter J. L. De Visschere & Igor Tsaur. (2018) Imaging modalities in synchronous oligometastatic prostate cancer. World Journal of Urology 37:12, pages 2573-2583.
Crossref
Crossref
Seong-Jang KimSang Woo Lee. (2019)
Diagnostic accuracy of
18
F flucholine PET/CT for preoperative lymph node staging in newly diagnosed prostate cancer patients; a systematic review and meta-analysis
. The British Journal of Radiology 92:1101, pages 20190193.
Crossref
Crossref
I. Brenot-Rossi & P.Y. Salaün. (2019) Cancers de la prostate. Médecine Nucléaire 43:1, pages 77-84.
Crossref
Crossref
Yu Guo, Ling Wang, Junjie Hu, Dehong Feng & Lijuan Xu. (2018) Diagnostic performance of choline PET/CT for the detection of bone metastasis in prostate cancer: A systematic review and meta-analysis. PLOS ONE 13:9, pages e0203400.
Crossref
Crossref
Gary JR Cook & Vicky Goh. (2018) Functional and Hybrid Imaging of Bone Metastases. Journal of Bone and Mineral Research 33:6, pages 961-972.
Crossref
Crossref
Roger Li, Gregory C. Ravizzini, Michael A. Gorin, Tobias Maurer, Matthias Eiber, Matthew R. Cooperberg, Mehrdad Alemozzaffar, Matthew K. Tollefson, Scott E. Delacroix & Brian F. Chapin. (2017) The use of PET/CT in prostate cancer. Prostate Cancer and Prostatic Diseases 21:1, pages 4-21.
Crossref
Crossref
Henrik Kjölhede, Helen Almquist, Kerstin Lyttkens & Ola Bratt. (2017) A population-based study of the clinical utility of 18F–choline PET/CT for primary metastasis staging of high-risk prostate cancer. European Journal of Hybrid Imaging 1:1.
Crossref
Crossref
Kathryn L. WallittSairah R. KhanSuraiya DubashHenry H. TamSameer KhanTara D. Barwick. (2017) Clinical PET Imaging in Prostate Cancer. RadioGraphics 37:5, pages 1512-1536.
Crossref
Crossref
J. Cardona Arboniés, B. Rodríguez Alfonso, J. Mucientes Rasilla, C. Martínez Ballesteros, I. Zapata Paz, A. Prieto Soriano, J. Carballido Rodriguez & M. Mitjavila Casanovas. (2017) 18 F-Choline PET/CT scan in staging and biochemical recurrence in prostate cancer patients: Changes in classification and radiotherapy planning. Revista Española de Medicina Nuclear e Imagen Molecular (English Edition) 36:5, pages 292-297.
Crossref
Crossref
J. Cardona Arboniés, B. Rodríguez Alfonso, J. Mucientes Rasilla, C. Martínez Ballesteros, I. Zapata Paz, A. Prieto Soriano, J. Carballido Rodriguez & M. Mitjavila Casanovas. (2017) La PET/TC con 18 F-Colina en la estadificación y recidiva bioquímica de pacientes con cáncer de próstata: cambios en la clasificación y planificación de radioterapia. Revista Española de Medicina Nuclear e Imagen Molecular 36:5, pages 292-297.
Crossref
Crossref
A.L. Giraudet, D. Kryza & A. Flechon. (2017) La TEP au 68Ga-PSMA et autres traceurs TEP. Médecine Nucléaire 41:3, pages 223-227.
Crossref
Crossref
A. J. Conde-Moreno, G. Herrando-Parreño, R. Muelas-Soria, J. Ferrer-Rebolleda, R. Broseta-Torres, M. P. Cozar-Santiago, F. García-Piñón & C. Ferrer-Albiach. (2016) Whole-body diffusion-weighted magnetic resonance imaging (WB-DW-MRI) vs choline-positron emission tomography-computed tomography (choline-PET/CT) for selecting treatments in recurrent prostate cancer. Clinical and Translational Oncology 19:5, pages 553-561.
Crossref
Crossref
Marina Hodolič. (2017) Imaging of Prostate Cancer Using 18 F-Choline PET/Computed Tomography. PET Clinics 12:2, pages 173-184.
Crossref
Crossref
Fabio Zattoni, Filiberto Zattoni & Laura Evangelista. (2017) Re: Marlon Perera, Nathan Papa, Daniel Christidis, et al. Sensitivity, Specificity, and Predictors of Positive 68 Ga–Prostate-specific Membrane Antigen Positron Emission Tomography in Advanced Prostate Cancer: A Systematic Review and Meta-analysis. Eur Urol 2016;70:926–37. European Urology 71:2, pages e64-e65.
Crossref
Crossref
Karolien E. Goffin & Wouter Everaerts. 2017. Management of Prostate Cancer. Management of Prostate Cancer
127
141
.
Gary J. R. Cook, Gurdip Azad & Anwar R. Padhani. (2016) Bone imaging in prostate cancer: the evolving roles of nuclear medicine and radiology. Clinical and Translational Imaging 4:6, pages 439-447.
Crossref
Crossref
Paolo Castellucci, Francesco Ceci, Tiziano Graziani & Stefano Fanti. (2016) PET imaging in prostate cancer, state of the art: a review of 18F-choline and 11C-choline PET/CT applications. Clinical and Translational Imaging 4:6, pages 449-456.
Crossref
Crossref
Sascha Nitsch, Oliver W. Hakenberg, Martin Heuschkel, Desiree Dräger, Guido Hildebrandt, Bernd J. Krause & Sarah M. Schwarzenböck. (2016)
Evaluation of Prostate Cancer with
11
C- and
18
F-Choline PET/CT: Diagnosis and Initial Staging
. Journal of Nuclear Medicine 57:Supplement 3, pages 38S-42S.
Crossref
Crossref
J. Hernández Pinzón, C. Ferrarotti, L. Ferrari, D. Mena, N. Larrañaga, J.C. Gallo & M. Bastianello. (2016) Cáncer de próstata: concordancia entre PET 18F-colina y TC en recaída bioquímica. Revista Argentina de Radiología 80:4, pages 241-251.
Crossref
Crossref
Laura Evangelista, Francesco Bertoldo, Francesco Boccardo, Giario Conti, Ilario Menchi, Francesco Mungai, Umberto Ricardi & Emilio Bombardieri. (2016) Diagnostic imaging to detect and evaluate response to therapy in bone metastases from prostate cancer: current modalities and new horizons. European Journal of Nuclear Medicine and Molecular Imaging 43:8, pages 1546-1562.
Crossref
Crossref
T. Maurer, H. Kübler, J.E. Gschwend & M. Eiber. (2015) Positronenemissionstomographie bei urologischen TumorerkrankungenPositron-emission tomography in urooncology. Der Urologe 54:7, pages 983-991.
Crossref
Crossref